Shaquille Vayda
Principal at Lux Capital
San Francisco Bay Area
Overview
Work Experience
Principal
2020 - Current
Lux Capital is an investment firm that invests in counter-conventional, seed-stage science and technology ventures.
Board Member
2022
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Raised $37,200,000.00 from Menlo Ventures, Air Street Capital, Obvious Ventures, Lux Capital, Expeditions Fund, Catalio Capital Management, Mei Z. and Khosla Ventures.
Board Member
2022
Atavistik Bio is a biotechnology company that focuses on the discovery and development of novel therapies for metabolic diseases and cancer.
Raised $100,000,000.00 from Lux Capital, Nextech Invest and The Column Group.
Board Member
2022
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Raised $40,000,000.00 from DCVC Bio, BioBrit, Lux Capital, Casdin Capital and Alexandria Venture Investments.
Board Member
2022
Board Member
2022
Board Member
2022
Board Member
2022
Board Member
2022
Rivet is a healthcare revenue acceleration platform that provides tools for medical practices to manage contracts, claims, and revenue.
Raised $31,500,000.00 from Catalyst Investors, Ankona Capital Partners, Pelion Venture Partners, Menlo Ventures and Lux Capital.
Consultant
2019 - 2020
EY-Parthenon is one of the leading management advisory firms in the payments industry